Biotech · Private company
Laekna Limited
Track this companyFree. Adds Laekna Limited to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- AfuresertibPhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- AfuresertibPhase 2 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 2 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Phase I and Phase II: LAE001/prednisone + afuresertibPhase 2 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- LAE102 IVPhase 1 · PostmenopausalClinicalTrials.gov · fetched Nov 12, 2026
- LAE102 SCPhase 1 · PostmenopausalClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal WomenPHASE1 · COMPLETED · started Apr 22, 2025ClinicalTrials.gov NCT06908707 · fetched Nov 12, 2026
- Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 18, 2022ClinicalTrials.gov NCT04851613 · fetched Nov 12, 2026
- Study With Afuresertib and Paclitaxel in Platinum Resistant OvarianPHASE2 · COMPLETED · started Jul 7, 2020ClinicalTrials.gov NCT04374630 · fetched Nov 12, 2026
- Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPCPHASE1_PHASE2 · COMPLETED · started Sep 13, 2019ClinicalTrials.gov NCT04060394 · fetched Nov 12, 2026